AMRZ trades 31.5% below Wall Street's consensus target of $67.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes AMRZ achieves its forward estimates and maintains a stable P/E multiple of 18.2x. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Amrize Ltd (AMRZ) has a Wall Street consensus price target of $67.00, based on estimates from 8 covering analysts. With the stock currently trading at $50.94, this represents a potential upside of +31.5%. The company has a market capitalization of $28.16B.
Analyst price targets range from a low of $58.00 to a high of $75.00, representing a 25% spread in expectations. The median target of $68.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, AMRZ trades at a trailing P/E of 23.8x and forward P/E of 18.2x. Analysts expect EPS to grow +34.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $46.65, with bear and bull scenarios of $29.39 and $61.47 respectively. Model confidence stands at 36/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
VMCVulcan Materials Company | $38.9B | $299.90 | $322.10 | +7.4% | Buy | 32.5x | 36 |
MLMMartin Marietta Materials, Inc. | $35.8B | $594.17 | $684.55 | +15.2% | Buy | 31.1x | 40 |
EXPEagle Materials Inc. | $6.6B | $213.02 | $220.00 | +3.3% | Buy | 16.5x | 25 |
CRHCRH plc | $71.0B | $106.21 | $140.92 | +32.7% | Buy | 17.9x | 20 |
FYBRFrontier Communications Parent, Inc. | $9.6B | $38.49 | $34.33 | -10.8% | Buy | — | 11 |
BCPCBalchem Corporation | $5.4B | $168.11 | $175.50 | +4.4% | Buy | 32.1x | 10 |
USLMUnited States Lime & Minerals, Inc. | $2.9B | $99.86 | $138.00 | +38.2% | Buy | 19.4x | 1 |
CATCaterpillar Inc. | $437.4B | $940.12 | $906.87 | -3.5% | Buy | 38.1x | 56 |
DEDeere & Company | $162.9B | $603.61 | $691.58 | +14.6% | Hold | 33.4x | 46 |
URIUnited Rentals, Inc. | $66.2B | $1056.02 | $1133.75 | +7.4% | Buy | 22.4x | 41 |
Quick answers to the most common questions about buying AMRZ stock.
The consensus Wall Street price target for AMRZ is $67, representing 31.5% upside from the current price of $50.94. With 8 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
AMRZ has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $67 implies 31.5% upside from current levels.
With a forward P/E of 18.1864x, AMRZ trades at a relatively low valuation. The consensus target of $67 implies 31.5% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $75 for AMRZ, while the most conservative target is $58. The consensus of $67 represents the median expectation. Our quantitative valuation model projects a bull case target of $61 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
AMRZ is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AMRZ stock forecast based on 8 Wall Street analysts shows a consensus price target of $67, with estimates ranging from $58 (bear case) to $75 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $47, with bear/bull scenarios of $29/$61.
Our quantitative valuation model calculates AMRZ's fair value at $47 (base case), with a bear case of $29 and bull case of $61. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 36/100.
AMRZ trades at a forward P/E ratio of 18.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 23.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on AMRZ, with a "Buy" consensus rating and $67 price target (31.5% upside). 6 of 8 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AMRZ analyst price targets range from $58 to $75, a 25% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $67 consensus represents the middle ground. Our model's $29-$61 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.